Treatment of clozapine associated obesity and diabetes with exenatide in people with schizophrenia
收藏Research Data Australia2024-12-14 收录
下载链接：
https://researchdata.edu.au/treatment-clozapine-associated-people-schizophrenia/2538456
下载链接
链接失效反馈官方服务：
资源简介：
Twenty-eight outpatients with schizophrenia (aged 18-64 years) were randomized to once-weekly extended-release subcutaneous exenatide or usual care for 24 weeks. The primary outcome was proportion of participants with >5% weight loss. All 28 participants completed the study; 3/14 in the exenatide group and 2/14 in the usual care group had type 2 diabetes.
提供机构：
Health Data Australia Contributor Records
